Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A number of patients with adrenal incidentaloma are exposed to a slight degree of cortisol excess resulting from functional autonomy of the adrenal mass (usually a cortical adenoma). At present, there are only scant data on the unwanted effects of this endocrine condition referred to as subclinical Cushing's syndrome. The aim of the present study was to look for some features of the metabolic syndrome in patients with incidental adrenal adenoma. Forty-one patients (9 men and 32 women) bearing adrenal incidentaloma with typical computed tomography features of cortical adenoma were studied. For both patients and controls, exclusion criteria were age equal to 70 yr or greater, previous history of fasting hyperglycemia, or impaired glucose tolerance (IGT), severe hypertension, current use of medication or concomitant relevant illnesses, and body mass index (BMI) equal to 30 kg/m(2) or greater. Forty-one patients with euthyroid multinodular goiter accurately matched for sex, age, and BMI served for a 1:1 case-control analysis. The study design included an oral glucose tolerance test (75 g) and an endocrine workup aimed at the study of the hypothalamic-pituitary-adrenal axis. Age and BMI were fully comparable between patients (54.0 +/- 10.7 yr, 23.8 +/- 2.4 kg/m(2)) and controls (52.2 +/- 11.6 yr, 23.5 +/- 2.8 kg/m(2)). Fasting glucose and fasting insulin levels were not different between the two groups (4.96 +/- 0.61 mmol/liter vs. 4.88 +/- 0.58 mmol/liter; 67 +/- 34 pmol/liter vs. 59 +/- 32 pmol/liter), but the 2-h postchallenge glucose was significantly higher in patients than in controls (7.43 +/- 2.49 mmol/liter vs. 6.10 plus minus 1.44 mmol/liter, P = 0.01). Fifteen patients (36%) reached the World Health Organization criteria for IGT and two other patients (5%) reached those for diabetes, and 14% of the controls qualified for IGT (P = 0.01). No difference in the lipid pattern was seen between the two groups, but either systolic or diastolic blood pressure were higher in patients (135.4 +/- 15.5 mm Hg vs. 125.0 +/- 15.6 mm Hg, P = 0.003; 82.9 +/- 9.1 mm Hg vs. 75.3 +/- 6.6 mm Hg, P < 0.0001). We calculated the whole-body insulin sensitivity index derived from the oral glucose tolerance test that was significantly reduced in the patients (4.3 +/- 1.7 vs. 5.7 +/- 2.5, P = 0.01). In a multiple regression analysis, 2-h glucose was associated with BMI and midnight cortisol values (r(2) = 0.36, P = 0.002). The comparison of the patients with nonfunctioning adenoma (n = 29) with those with subclinical Cushing's syndrome (n = 12) yielded significant differences as to 2-h glucose and triglyceride levels, which were significantly higher in the second group (7.02 +/- 1.76 mmol/liter vs. 8.72 +/- 3.17 mmol/liter, P = 0.03; 1.06 +/- 0.4 mmol/liter vs. 1.73 +/- 0.96 mmol/liter, P = 0.002), but the insulin sensitivity index was conversely reduced (5.2 +/- 1.4 vs. 2.9 +/- 1.2, P < 0.0001). In conclusion, many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls. The slight hypercortisolism observed in some such patients may significantly contribute to this state of insulin resistance. Midnight serum cortisol appears as a sensitive marker of the metabolic effects of subclinical Cushing's syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The -mg dexamethasone overnight suppression test is recommended for screening patients with AI for SCS, setting the threshold at nmol/L; a value of nmol/L virtually excludes SCS, whereas values between and nmol/L occupy an area of uncertainty ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
RIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696 · cited 1×
“The effect of glucocorticoids in vivo appears to include both impaired insulin-dependent glucose uptake in the periphery and enhanced gluconeogenesis in the liver (42).”
BackgroundHow to measure insulin sensitivity
Ferrannini, E., & Mari, A. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00001 · Cited by 512
Insulin Resistance and Cardiovascular Disease1
McFarlane, S. I., Banerji, M., & Sowers, J. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7202 · Cited by 501
MANAGEMENT APPROACHES TO ADRENAL INCIDENTALOMAS
Young, W. F. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70122-5 · Cited by 415
ROSS, E. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92749-0 · Cited by 390 · cited 1×
“The balance of these effects may be important in determining whether insulin resistance is accompanied by compensatory hyperinsulinemia, or hyperglycemia, in Cushing’s syndrome (44).”
BackgroundInsulin Resistance and Cardiovascular Disease
McFarlane, S. I. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.713 · Cited by 377
Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
Korobkin, M., Brodeur, F. J., Yutzy, G. G., Francis, I. R., Quint, L. E., Dunnick, N. R., & Kazerooni, E. A. (1996) · American Journal of Roentgenology · doi:10.2214/ajr.166.3.8623622 · Cited by 365
Boscaro, M., Barzon, L., Fallo, F., & Sonino, N. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04172-6 · Cited by 350
Reincke, M. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.826 · Cited by 348
Hormonal Evaluation of the Patient with an Incidentally Discovered Adrenal Mass
Desforges, J. F., Ross, N. S., & Aron, D. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011153232007 · Cited by 340
The Cushing Syndrome: An Update on Diagnostic Tests
Kaye, T. B., & Crapo, L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-434 · Cited by 310
Subclinical Cushing’s syndrome
Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285
CLINICAL REVIEW 26 Insulin Resistance in Obese and Nonobese Man
CARO, J. F. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-4-691 · Cited by 279
Increased Mortality Associated with Diabetic Foot Ulcer
Boyko, E. J., Ahroni, J. H., Smith, D. G., & Davignon, D. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199611)13:11<967::aid-dia266>3.0.co;2-k · Cited by 270
Cushing, Cortisol, and Cardiovascular Disease
Whitworth, J. A., Mangos, G. J., & Kelly, J. J. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.912 · Cited by 259
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 254
Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
Osella, G., Terzolo, M., Borretta, G., Magro, G., Alí, A., Piovesan, A., Paccotti, P., & Angeli, A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989452 · Cited by 206
Self-citationPapanicolaou, D. A., Yanovski, J. A., Cutler, G. B., Chrousos, G. P., & Nieman, L. K. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4733 · Cited by 201
Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo, Osella, Alì, Borretta, Cesario, Paccotti, & Angeli, A. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00357.x · Cited by 198 · cited 7×
“The association of at least two of these criteria qualified a patient for subclinical Cushing’s syndrome (16).”
BackgroundMethodInfluentialSelf-citationSmall adenomas of the adrenal cortex in hypertension and diabetes
RUSSI, S. (1945) · Archives of Internal Medicine · doi:10.1001/archinte.1945.00210350030005 · Cited by 161 · cited 1×
“The problem is not trivial because adrenal masses are frequent in the aged population, as demonstrated by autopsy studies (2, 3), and they are currently being found (serendipitously) in millions of people worldwide (4, 5).”
BackgroundIntegrated imaging of adrenal disease.
Francis, I. R., Gross, M. D., Shapiro, B., KOROBKIN, M. T., & Quint, L. E. (1992) · Radiology · doi:10.1148/radiology.184.1.1609063 · Cited by 151
Delayed enhanced CT for differentiation of benign from malignant adrenal masses.
Korobkin, M., Brodeur, F. J., Francis, I. R., Quint, L. E., Dunnick, N. R., & Goodsitt, M. (1996) · Radiology · doi:10.1148/radiology.200.3.8756924 · Cited by 151
The Clinical Implications of Impaired Glucose Tolerance
Alberti, K. G. M. M. (1996) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199611)13:11<927::aid-dia279>3.0.co;2-e · Cited by 149
FRIEDMAN, T. C., MASTORAKOS, G., NEWMAN, T. D., MULLEN, N. M., HORTON, E. G., COSTELLO, R., PAPADOPOULOS, N. M., & CHROUSOS, G. P. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.645 · Cited by 145
Chidiac, R. M., & Aron, D. C. (1997) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70242-5 · Cited by 140
Abnormalities of endocrine function in patients with clinically silent adrenal masses.
Ambrosi, B., Peverelli, S., Passini, E., Re, T., Ferrario, R., Colombo, P., Sartorio, A., & Faglia, G. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1320422 · Cited by 136
Adrenal incidentalomas: a manifestation of the metabolic syndrome?
Reincke, M., Faßnacht, M., Väth, S., Mora, P., & Allolio, B. (1996) · Endocrine Research · doi:10.1080/07435809609043773 · Cited by 133 · cited 1×
“They observed a proliferative effect of insulin on an adrenal cancer cell line without any effect on cortisol synthesis and suggested that hyperinsulinemia may have a pathogenetic role since it occurs in polycystic ovary syndrome (24).”
BackgroundAdenomas of the adrenal cortex
COMMONS, R. R. (1948) · Archives of Internal Medicine · doi:10.1001/archinte.1948.00220190045004 · Cited by 121
Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours
Fernández‐Real, J. M., Ricart Engel, W., Simó, R., Salinas, I., Webb, S. M., & and the Study Group of Incidental Adrenal Adenoma (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00437.x · Cited by 109 · cited 2×
“However, the results of that study were not adjusted for body weight, and no control group was included (38).”
BackgroundEpidemiology of Cushing’s Syndrome and Subclinical Disease
Ross, N. S. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30082-3 · Cited by 104
Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study
Garancini, M. P., Calori, G., Ruotolo, G., Manara, E., Izzo, A., Ebbli, E., Bozzetti, A., Boari, L., Lazzari, P., & Gallus, G. (1995) · Diabetologia · doi:10.1007/bf00400635 · Cited by 86
Insulin hypersecretion: A distinctive feature between essential and secondary hypertension
Sechi, L. A., Melis, A., & Tedde, R. (1992) · Metabolism · doi:10.1016/0026-0495(92)90019-7 · Cited by 80
A-I-D-S: the new endocrine epidemic
Griffing, G. T. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.6.1530 · Cited by 71
Cook, D. M., & Loriaux, D. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00082-4 · Cited by 66
DIAGNOSIS AND TREATMENT OF ADRENAL INCIDENTALOMA
Kievit, J., & Haak, H. R. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70117-1 · Cited by 55
Stubbs, M., & York, D. A. (1991) · PubMed · Cited by 50
Scintigraphic Endocrine Mimicry
Gross, M. D., Shapiro, B., & Freitas, J. E. (1990) · Clinical Nuclear Medicine · doi:10.1097/00003072-199007000-00001 · Cited by 2
Cited by
Diagnosis and complications of Cushing’s syndrome: a consensus statement
Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362
Self-citationThe Incidentally Discovered Adrenal Mass
Young, W. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp065470 · Cited by 1,096
The trans-ancestral genomic architecture of glycemic traits
Chen, J., Spracklen, C. N., Marenne, G., Varshney, A., Corbin, L. J., Luan, J., Willems, S. M., Wu, Y., Zhang, X., Horikoshi, M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00852-9 · Cited by 793
The clinically inapparent adrenal mass: update in diagnosis and management
Mansmann, G., Lau, J., Balk, E., Rothberg, M., Miyachi, Y., & Bornstein, S. R. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0031 · Cited by 781
Prevalence and natural history of adrenal incidentalomas
Barzon, L., Sonino, N., Fallo, F., Palu, G., & Boscaro, M. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490273 · Cited by 642
Metadata
- Authors
- Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-03
- Volume
- 87
- Issue
- 3
- Pages
- 998-1003
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109181100
- Cited by
- 322
- References
- 44
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3 · 2023: 16 · 2022: 9 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 10 · 2016: 7 · 2015: 18 · 2014: 15 · 2013: 16 · 2012: 20
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal incidentaloma, subclinical Cushing's syndrome, metabolic syndrome, adrenal adenoma, impaired glucose tolerance, diabetes mellitus, hypertension, hypothalamic-pituitary-adrenal axis, cortisol excess, oral glucose tolerance test, body mass index, lipid profile, insulin resistance, obesity-related hypertension, obesity-related diabetes
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Blood Pressure, Cushing Syndrome, Female, Humans, Insulin, Male, Middle Aged, Reference Values, Body Mass Index, Case-Control Studies, Glucose Intolerance, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.